The non-NRG signature exhibited significant correlations (P < 0.05) with several clinical features, including gender, tumor stage, T classification, lymph node metastasis, and distal metastasis, as well as mutational features such as EGFR mutation, KRAS mutation, and TP53 mutation (Figure S3). Here, KRAS is linked to neoplasm.